thyroxine has been researched along with Graves Ophthalmopathy in 52 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Graves Ophthalmopathy: An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "MP group than the TG group experienced adverse events." | 7.01 | Efficacy and safety of tripterygium glycosides for active moderate to severe Graves' ophthalmopathy: a randomised, observer-masked, single-centre trial. ( Liu, J; Lu, B; Shao, J; Wang, J; Ye, X; Zhao, H, 2021) |
| "Graves' disease is the most common cause of hyperthyroidism." | 6.66 | Effect of Addition of Thyroxine in the Treatment of Graves' Disease: A Systematic Review. ( Bai, L; Li, J; Wei, F; Wei, J; Wei, M; Xiao, Y; Yan, W, 2020) |
| "Euthyroidism was defined as both serum thyrotropin (thyroid-stimulating hormone [TSH]) and free thyroxine (FT4) within their reference ranges or, when only one was available, it was within its reference range; hypothyroidism as TSH ≥ 10 mU/L, or subnormal FT4 regardless of TSH; hyperthyroidism as TSH below and FT4 above their reference ranges; dysthyroidism as the sum of hypo- and hyperthyroidism; subclinical hypothyroidism as normal FT4 and TSH between the upper limit of normal and <10 mU/L; and subclinical hyperthyroidism as low TSH and normal FT4." | 4.12 | Postradioiodine Graves' management: The PRAGMA study. ( Abraham, P; Atkin, SL; Basu, A; Bennett, S; Boelaert, K; Crown, A; Dayan, C; Drake, WM; Falinska, A; Gibb, FW; Gilbert, J; Gleeson, H; Grossman, A; Hickey, J; Jarvis, S; Johnson, A; Johnston, C; Jones, TH; Karavitaki, N; Lazarus, JH; Leese, GP; Levy, MJ; Madathil, A; Malik, I; Mishra, B; Moran, C; Nag, S; Orme, SM; Pariani, N; Perros, P; Plummer, Z; Ray, DW; Razvi, S; Rees, A; Sanderson, V; Sathyapalan, T; Sturrock, N; Syed, AA; Vaidya, B; Velusamy, A; Williams, GR; Žarković, MP, 2022) |
| "The novel peptides markedly reduced thyroid size, serum thyroxine levels, retro-orbital fibrosis, and tachycardia in Ad-TSHR289-immunized mice." | 3.91 | Therapeutic Effects of Short Cyclic and Combined Epitope Peptides in a Long-Term Model of Graves' Disease and Orbitopathy. ( Faßbender, J; Holthoff, HP; Li, Z; Ungerer, M, 2019) |
| "0 mL, but we observed severe hyperthyroidism with elevated serum free triiodothyronine, free thyroxine, and thyrotropin receptor antibody levels." | 3.78 | Severe Graves' ophthalmopathy after percutaneous ethanol injection in a nontoxic thyroid nodule. ( Le Moli, R; Muscia, V; Pezzino, V; Regalbuto, C; Russo, M; Vigneri, R, 2012) |
| "MP group than the TG group experienced adverse events." | 3.01 | Efficacy and safety of tripterygium glycosides for active moderate to severe Graves' ophthalmopathy: a randomised, observer-masked, single-centre trial. ( Liu, J; Lu, B; Shao, J; Wang, J; Ye, X; Zhao, H, 2021) |
| "To compare the therapeutic effect and side effect of the treatments on hyperthyroid exophthalmos with the combination of acupuncture and medication and with medication only." | 2.75 | [Therapeutic effect and side effect of treatment on hyperthyroid exophthalmos with the combination of acupuncture and medication]. ( He, JS; Li, Y; Liu, SM; Shu, S; Xia, Y, 2010) |
| "Graves' disease is the most common cause of hyperthyroidism." | 2.66 | Effect of Addition of Thyroxine in the Treatment of Graves' Disease: A Systematic Review. ( Bai, L; Li, J; Wei, F; Wei, J; Wei, M; Xiao, Y; Yan, W, 2020) |
| "Autoimmune reactions in Graves' disease (GD) occur not only in the thyroid gland, but also in the orbital connective tissue, eyelids, extraocular muscles." | 1.56 | Radioiodine therapy and Graves' disease - Myths and reality. ( Borowska, M; Czarnywojtek, A; Gut, P; Karlińska, M; Kobylecka, M; Krolicki, L; Plazinska, MT; Prasek, K; Ruchala, M; Sawicka-Gutaj, N; Wolinski, K; Zgorzalewicz-Stachowiak, M, 2020) |
| "Hyperthyroidism is a significant contributor to oxidative stress in patients with active TAO, which manifests as upregulated lipid peroxidation and antioxidant system activation." | 1.56 | The effect of thyroid hormone status on selected antioxidant parameters in patients with Graves' disease and active thyroid-associated orbitopathy. ( Kos-Kudła, B; Londzin-Olesik, M; Nowak, A; Nowak, M; Wielkoszyński, T, 2020) |
| "Graves' disease is the most common form of autoimmune thyroid disorder, characterized by hyperthyroidism due to circulating autoantibodies." | 1.46 | Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice. ( Hu, X; Niu, M; Song, S; Wang, H; Wang, J; Xia, N; Xu, H; Ye, X, 2017) |
| "A 44-year-old male with Graves' disease ongoing for seven years presented bilateral ophthalmopathy and myxoedema of the big toes." | 1.39 | [Graves' dermopathy on the big toe]. ( Cante, V; Couderc, E; Guillet, G; Renaud, O, 2013) |
| "Prednisone was started 1 d after RAI and withdrawn after 6 wk." | 1.36 | Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves' orbitopathy: a retrospective cohort study. ( Bartalena, L; Compri, E; Lai, A; Marino, F; Piantanida, E; Sassi, L; Sivelli, P; Tanda, ML, 2010) |
| "The association of infiltrative ophthalmopathy with primary hypothyroidism is uncommon." | 1.35 | Infiltrative ophthalmopathy and primary hypothyroidism: a rare clinical manifestation of a common disease. ( Dhingra, A; Kumar, K; Rajput, R; Sen, J, 2009) |
| "For patients with TOA, orbital decompression seems to be an effective and safe treatment." | 1.34 | Efficacy and safety of orbital decompression in treatment of thyroid-associated ophthalmopathy: long-term follow-up of 78 patients. ( Jernfors, M; Laitinen, K; Malmberg, H; Pitkäranta, A; Setälä, K; Välimäki, MJ, 2007) |
| "We believe that RTX treatment in Graves' disease may cause amelioration of ophthalmopathy by depleting total lymphocytes population in the orbit." | 1.33 | Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression. ( Avignone, S; Beck-Peccoz, P; Bonara, P; Campi, I; Guastella, C; Pirola, G; Ratiglia, R; Rossi, S; Salvi, M; Sbrozzi, F; Vannucchi, G, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (5.77) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (23.08) | 29.6817 |
| 2010's | 28 (53.85) | 24.3611 |
| 2020's | 9 (17.31) | 2.80 |
| Authors | Studies |
|---|---|
| Perros, P | 1 |
| Basu, A | 1 |
| Boelaert, K | 1 |
| Dayan, C | 1 |
| Vaidya, B | 1 |
| Williams, GR | 1 |
| Lazarus, JH | 1 |
| Hickey, J | 1 |
| Drake, WM | 1 |
| Crown, A | 1 |
| Orme, SM | 1 |
| Johnson, A | 1 |
| Ray, DW | 1 |
| Leese, GP | 1 |
| Jones, TH | 1 |
| Abraham, P | 1 |
| Grossman, A | 1 |
| Rees, A | 1 |
| Razvi, S | 1 |
| Gibb, FW | 1 |
| Moran, C | 1 |
| Madathil, A | 1 |
| Žarković, MP | 1 |
| Plummer, Z | 1 |
| Jarvis, S | 1 |
| Falinska, A | 1 |
| Velusamy, A | 1 |
| Sanderson, V | 1 |
| Pariani, N | 1 |
| Atkin, SL | 1 |
| Syed, AA | 1 |
| Sathyapalan, T | 1 |
| Nag, S | 1 |
| Gilbert, J | 1 |
| Gleeson, H | 1 |
| Levy, MJ | 1 |
| Johnston, C | 1 |
| Sturrock, N | 1 |
| Bennett, S | 1 |
| Mishra, B | 1 |
| Malik, I | 1 |
| Karavitaki, N | 1 |
| Nakano, M | 1 |
| Konishi, H | 1 |
| Koshiba, M | 1 |
| Zhou, J | 1 |
| Yu, X | 1 |
| Lou, Y | 1 |
| Bao, J | 1 |
| Xia, Y | 2 |
| Zhu, L | 1 |
| Katahira, M | 1 |
| Tsunekawa, T | 1 |
| Mizoguchi, A | 1 |
| Yamaguchi, M | 1 |
| Tsuru, K | 1 |
| Takashima, H | 1 |
| Terada, R | 1 |
| Plazinska, MT | 1 |
| Sawicka-Gutaj, N | 2 |
| Czarnywojtek, A | 1 |
| Wolinski, K | 1 |
| Kobylecka, M | 1 |
| Karlińska, M | 1 |
| Prasek, K | 1 |
| Zgorzalewicz-Stachowiak, M | 1 |
| Borowska, M | 1 |
| Gut, P | 1 |
| Ruchala, M | 1 |
| Krolicki, L | 1 |
| Londzin-Olesik, M | 1 |
| Kos-Kudła, B | 1 |
| Nowak, A | 1 |
| Wielkoszyński, T | 1 |
| Nowak, M | 2 |
| Khamisi, S | 1 |
| Lundqvist, M | 1 |
| Emadi, P | 1 |
| Almby, K | 1 |
| Ljunggren, Ö | 1 |
| Karlsson, FA | 1 |
| Ye, X | 2 |
| Zhao, H | 1 |
| Liu, J | 1 |
| Lu, B | 1 |
| Shao, J | 1 |
| Wang, J | 2 |
| Li, J | 1 |
| Bai, L | 1 |
| Wei, F | 1 |
| Wei, M | 1 |
| Xiao, Y | 1 |
| Yan, W | 1 |
| Wei, J | 1 |
| Xia, N | 2 |
| Hu, X | 1 |
| Song, S | 1 |
| Xu, H | 1 |
| Niu, M | 1 |
| Wang, H | 1 |
| Meringolo, D | 1 |
| Campi, I | 2 |
| Costante, G | 1 |
| Machen, L | 1 |
| MacIntosh, P | 1 |
| Neumann, S | 1 |
| Krieger, CC | 1 |
| Gershengorn, MC | 1 |
| Smith, TJ | 2 |
| Scanlan, TS | 2 |
| Fernando, R | 2 |
| Faßbender, J | 1 |
| Holthoff, HP | 1 |
| Li, Z | 1 |
| Ungerer, M | 1 |
| Couderc, E | 1 |
| Cante, V | 1 |
| Renaud, O | 1 |
| Guillet, G | 1 |
| Batra, R | 1 |
| Krishnasamy, SK | 1 |
| Buch, H | 1 |
| Sandramouli, S | 1 |
| Bruscolini, A | 1 |
| Abbouda, A | 1 |
| Locuratolo, N | 1 |
| Restivo, L | 1 |
| Trimboli, P | 1 |
| Romanelli, F | 1 |
| Erdei, A | 1 |
| Paragh, G | 1 |
| Kovacs, P | 1 |
| Karanyi, Z | 1 |
| Berenyi, E | 1 |
| Galuska, L | 1 |
| Lenkey, A | 1 |
| Szabados, L | 1 |
| Gyory, F | 1 |
| Ujhelyi, B | 1 |
| Berta, A | 1 |
| Boda, J | 1 |
| Berta, E | 1 |
| Bodor, M | 1 |
| Gazdag, A | 1 |
| Nagy, EV | 1 |
| McElnea, E | 1 |
| Ní Mhéalóid, A | 1 |
| Moran, S | 1 |
| Kelly, R | 1 |
| Fulcher, T | 1 |
| Sendhil Kumaran, M | 1 |
| Dutta, P | 1 |
| Sakia, U | 1 |
| Dogra, S | 1 |
| Villagelin, D | 1 |
| Romaldini, JH | 1 |
| Santos, RB | 1 |
| Milkos, AB | 1 |
| Ward, LS | 1 |
| Budny, B | 1 |
| Zybek-Kocik, A | 1 |
| Sowiński, J | 1 |
| Ziemnicka, K | 1 |
| Waligórska-Stachura, J | 1 |
| Ruchała, M | 1 |
| Tu, Y | 1 |
| Wang, Y | 1 |
| Ding, L | 1 |
| Zhang, J | 1 |
| Wu, W | 1 |
| Karra, E | 1 |
| Yousseif, A | 1 |
| Rose, GE | 1 |
| Baldeweg, SE | 1 |
| Placzek, E | 1 |
| Reese, EA | 1 |
| Placzek, AT | 1 |
| Schwartz, S | 1 |
| Trierweiler, A | 1 |
| Niziol, LM | 1 |
| Raychaudhuri, N | 1 |
| Atkins, S | 1 |
| Grzesiuk, W | 1 |
| Szydlarska, D | 1 |
| Pragacz, A | 1 |
| Bar-Andziak, E | 1 |
| Sieminska, L | 1 |
| Niedziolka, D | 1 |
| Pillich, A | 1 |
| Kos-Kudla, B | 1 |
| Marek, B | 1 |
| Borgiel-Marek, H | 1 |
| Rajput, R | 1 |
| Dhingra, A | 1 |
| Kumar, K | 1 |
| Sen, J | 1 |
| Daroszewski, J | 1 |
| Pawlak, E | 1 |
| Karabon, L | 1 |
| Frydecka, I | 1 |
| Jonkisz, A | 1 |
| Slowik, M | 1 |
| Bolanowski, M | 1 |
| Yi, BP | 1 |
| Leng, SL | 1 |
| Kwang, LB | 1 |
| Rootman, J | 1 |
| Lai, A | 1 |
| Sassi, L | 1 |
| Compri, E | 1 |
| Marino, F | 1 |
| Sivelli, P | 1 |
| Piantanida, E | 1 |
| Tanda, ML | 1 |
| Bartalena, L | 1 |
| Akarsu, E | 1 |
| Buyukhatipoglu, H | 1 |
| Aktaran, S | 1 |
| Kurtul, N | 1 |
| Shu, S | 1 |
| Li, Y | 1 |
| Liu, SM | 1 |
| He, JS | 1 |
| Giovansili, L | 1 |
| Cayrolle, G | 1 |
| Belange, G | 1 |
| Clavel, G | 1 |
| Herdan, ML | 1 |
| Yoshihara, A | 1 |
| Yoshimura Noh, J | 1 |
| Nakachi, A | 1 |
| Ohye, H | 1 |
| Sato, S | 1 |
| Sekiya, K | 1 |
| Kosuga, Y | 1 |
| Suzuki, M | 1 |
| Matsumoto, M | 1 |
| Kunii, Y | 1 |
| Watanabe, N | 1 |
| Mukasa, K | 1 |
| Inoue, Y | 1 |
| Ito, K | 2 |
| Laurberg, P | 1 |
| Berman, DC | 1 |
| Andersen, S | 1 |
| Bülow Pedersen, I | 1 |
| Seoane Cruz, I | 1 |
| Penín Álvarez, M | 1 |
| Rodríguez Ferro, F | 1 |
| Luna Cano, R | 1 |
| Regalbuto, C | 1 |
| Le Moli, R | 1 |
| Muscia, V | 1 |
| Russo, M | 1 |
| Vigneri, R | 1 |
| Pezzino, V | 1 |
| Jang, SY | 1 |
| Lee, SY | 2 |
| Lee, EJ | 1 |
| Yoon, JS | 2 |
| Subekti, I | 1 |
| Boedisantoso, A | 1 |
| Moeloek, ND | 1 |
| Waspadji, S | 1 |
| Mansyur, M | 1 |
| Kim, SE | 1 |
| Kim, KH | 1 |
| CORDES, FC | 1 |
| TENGROTH, B | 1 |
| BROUHON-MASSILLON, L | 1 |
| Salvi, M | 1 |
| Vannucchi, G | 1 |
| Rossi, S | 1 |
| Bonara, P | 1 |
| Sbrozzi, F | 1 |
| Guastella, C | 1 |
| Avignone, S | 1 |
| Pirola, G | 1 |
| Ratiglia, R | 1 |
| Beck-Peccoz, P | 1 |
| Zhou, S | 1 |
| Liang, Y | 1 |
| Xiao, C | 1 |
| Shen, H | 1 |
| Pan, H | 1 |
| Deng, H | 1 |
| Wang, N | 1 |
| Li, QQ | 1 |
| Gopinath, B | 1 |
| Musselman, R | 1 |
| Adams, CL | 1 |
| Tani, J | 1 |
| Beard, N | 1 |
| Wall, JR | 1 |
| Velickiene, D | 1 |
| Kazanavicius, G | 1 |
| Danilevicius, J | 1 |
| Jankauskiene, J | 1 |
| Marcocci, C | 1 |
| Pinchera, A | 1 |
| Marinò, M | 1 |
| Jernfors, M | 1 |
| Välimäki, MJ | 1 |
| Setälä, K | 1 |
| Malmberg, H | 1 |
| Laitinen, K | 1 |
| Pitkäranta, A | 1 |
| Laban-Guceva, N | 1 |
| Antova, M | 1 |
| Bogoev, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease[NCT02316691] | 2 participants (Actual) | Observational | 2016-01-31 | Terminated | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for thyroxine and Graves Ophthalmopathy
| Article | Year |
|---|---|
Effect of Addition of Thyroxine in the Treatment of Graves' Disease: A Systematic Review.
Topics: Animals; Antithyroid Agents; Drug Therapy, Combination; Graves Disease; Graves Ophthalmopathy; Human | 2020 |
Post-radioiodine De Novo Onset Graves' Ophthalmopathy: Case Reports and a Review of the Literature.
Topics: Adult; Antithyroid Agents; Carbimazole; Diplopia; Graves Disease; Graves Ophthalmopathy; Humans; Hyp | 2015 |
Management of patients with thyroid eye disease.
Topics: Adrenal Cortex Hormones; Catheter Ablation; Graves Ophthalmopathy; Hormone Replacement Therapy; Huma | 2016 |
2 trials available for thyroxine and Graves Ophthalmopathy
| Article | Year |
|---|---|
Efficacy and safety of tripterygium glycosides for active moderate to severe Graves' ophthalmopathy: a randomised, observer-masked, single-centre trial.
Topics: Administration, Intravenous; Adult; Antithyroid Agents; Diplopia; Exophthalmos; Eye Pain; Female; Gl | 2021 |
[Therapeutic effect and side effect of treatment on hyperthyroid exophthalmos with the combination of acupuncture and medication].
Topics: Acupuncture Points; Acupuncture Therapy; Adult; Combined Modality Therapy; Drug-Related Side Effects | 2010 |
47 other studies available for thyroxine and Graves Ophthalmopathy
| Article | Year |
|---|---|
Postradioiodine Graves' management: The PRAGMA study.
Topics: Adult; Antithyroid Agents; Graves Disease; Graves Ophthalmopathy; Humans; Hyperthyroidism; Hypothyro | 2022 |
Thyroid-Stimulating Antibody/Thyroid-Stimulating Hormone Receptor Antibody Ratio as a Sensitive Screening Test for Active Graves' Orbitopathy.
Topics: Autoantibodies; Graves Disease; Graves Ophthalmopathy; Humans; Immunoglobulins, Thyroid-Stimulating; | 2022 |
Detection and Correlation Analysis of Serum Uric Acid in Patients with Thyroid-Associated Ophthalmopathy.
Topics: Glycated Hemoglobin; Graves Ophthalmopathy; Humans; Thyroid Hormones; Thyrotropin; Thyroxine; Triiod | 2022 |
Clinical significance of thyroglobulin antibodies and thyroid peroxidase antibodies in Graves' disease: a cross-sectional study.
Topics: Autoantibodies; Clinical Relevance; Cross-Sectional Studies; Graves Disease; Graves Ophthalmopathy; | 2023 |
Radioiodine therapy and Graves' disease - Myths and reality.
Topics: Adult; Aged; Anti-Inflammatory Agents; Cigarette Smoking; Female; Graves Disease; Graves Ophthalmopa | 2020 |
The effect of thyroid hormone status on selected antioxidant parameters in patients with Graves' disease and active thyroid-associated orbitopathy.
Topics: Adult; Female; Graves Ophthalmopathy; Humans; Hyperthyroidism; Male; Middle Aged; Oxidative Stress; | 2020 |
Serum thyroglobulin is associated with orbitopathy in Graves' disease.
Topics: Adult; Aged; Antithyroid Agents; Biomarkers; Female; Graves Disease; Graves Ophthalmopathy; Humans; | 2021 |
Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice.
Topics: 3T3 Cells; Animals; Autoantibodies; Disease Models, Animal; Electroporation; Enzyme-Linked Immunosor | 2017 |
Severe Graves' Orbitopathy occurring in a patient with thyroid hemiagenesis.
Topics: Adrenal Cortex Hormones; Autoantibodies; Autoantigens; Female; Graves Disease; Graves Ophthalmopathy | 2018 |
Considerations in Pediatric Proptosis.
Topics: Adolescent; Antithyroid Agents; Blepharoptosis; Cholinesterase Inhibitors; Drug Therapy, Combination | 2018 |
Letter to the Editor: "Elevated Serum Tetrac in Graves Disease: Potential Pathogenic Role in Thyroid-Associated Ophthalmopathy".
Topics: Graves Disease; Graves Ophthalmopathy; Humans; Thyroxine | 2019 |
Response to Letter to the Editor: "Elevated Serum Tetrac in Graves Disease: Potential Pathogenic Role in Thyroid-Associated Ophthalmopathy".
Topics: Graves Disease; Graves Ophthalmopathy; Humans; Thyroxine | 2019 |
Therapeutic Effects of Short Cyclic and Combined Epitope Peptides in a Long-Term Model of Graves' Disease and Orbitopathy.
Topics: Adenoviridae; Animals; Disease Models, Animal; Epitopes; Female; Fibrosis; Graves Ophthalmopathy; HE | 2019 |
[Graves' dermopathy on the big toe].
Topics: Adult; Biopsy; Carbimazole; Decompression, Surgical; Fibroblasts; Foot Dermatoses; Glycosaminoglycan | 2013 |
Dry Eye Syndrome in Non-Exophthalmic Graves' Disease.
Topics: Adult; Dry Eye Syndromes; Female; Graves Ophthalmopathy; Humans; Immunoglobulins, Thyroid-Stimulatin | 2015 |
Rapid response to and long-term effectiveness of anti-CD20 antibody in conventional therapy resistant Graves' orbitopathy: A five-year follow-up study.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Female; Follow-Up Studies; Graves Ophthalmopathy; Hum | 2014 |
Thyroid-like ophthalmopathy in a euthyroid patient receiving Ipilimumab.
Topics: Aged; Antibodies, Monoclonal; Euthyroid Sick Syndromes; Exophthalmos; Female; Glucocorticoids; Grave | 2014 |
Long-term follow-up and epidemiological trends in patients with pretibial myxedema: an 11-year study from a tertiary care center in northern India.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Clobetasol; Drug Therapy, Combination; | 2015 |
Outcomes in Relapsed Graves' Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole Treatment.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Graves Ophthalmopathy; Hormone Replacement Therap | 2015 |
Nicotinamide phosphoribosyltransferase leukocyte overexpression in Graves' opthalmopathy.
Topics: Adult; Autoantibodies; Body Mass Index; Cross-Sectional Studies; Female; Graves Ophthalmopathy; Huma | 2016 |
Development of a Novel Thyroid Function Fluctuated Animal Model for Thyroid-Associated Ophthalmopathy.
Topics: Animals; Body Weight; Disease Models, Animal; Drug Administration Schedule; Endoplasmic Reticulum; G | 2016 |
Elevated Serum Tetrac in Graves Disease: Potential Pathogenic Role in Thyroid-Associated Ophthalmopathy.
Topics: Adult; Aged; Aged, 80 and over; Autoradiography; Case-Control Studies; Cells, Cultured; Chromatograp | 2017 |
Thyroid-associated orbitopathy in patients with Hashimoto's thyroiditis: a case report.
Topics: Adult; Anemia, Pernicious; Autoantibodies; Graves Ophthalmopathy; Hashimoto Disease; Humans; Male; M | 2008 |
Serum concentrations of adiponectin and resistin in hyperthyroid Graves' disease patients.
Topics: Adiponectin; Autoantibodies; Female; Graves Ophthalmopathy; Humans; Male; Middle Aged; Regression An | 2008 |
Infiltrative ophthalmopathy and primary hypothyroidism: a rare clinical manifestation of a common disease.
Topics: Female; Graves Ophthalmopathy; Humans; Hypothyroidism; Male; Middle Aged; Thyroxine | 2009 |
Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD; Cohort Studies; CTLA-4 Antigen; DNA; Femal | 2009 |
Development of thyroid-related orbitopathy following cataract surgery.
Topics: Aged; Aged, 80 and over; Female; Follow-Up Studies; Graves Ophthalmopathy; Humans; Immunoglobulins, | 2009 |
Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves' orbitopathy: a retrospective cohort study.
Topics: Adult; Aged; Chi-Square Distribution; Female; Glucocorticoids; Graves Disease; Graves Ophthalmopathy | 2010 |
Effects of pulse methylprednisolone and oral methylprednisolone treatments on serum levels of oxidative stress markers in Graves' ophthalmopathy.
Topics: Adult; Anti-Inflammatory Agents; Female; Glutathione; Graves Ophthalmopathy; Humans; Iodide Peroxida | 2011 |
Graves' ophthalmopathy after total thyroidectomy for papillary carcinoma.
Topics: Autoantibodies; Carcinoma, Papillary; Female; Graves Ophthalmopathy; Humans; Immunoglobulins, Thyroi | 2011 |
Severe thyroid-associated orbitopathy in Hashimoto's thyroiditis. Report of 2 cases.
Topics: Adult; Female; Graves Ophthalmopathy; Hashimoto Disease; Humans; Magnetic Resonance Imaging; Methylp | 2011 |
Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
Topics: Adult; Antithyroid Agents; Biomarkers; Denmark; Drug Administration Schedule; Feasibility Studies; F | 2011 |
[Unilateral exophthalmos and hypothyroidism].
Topics: Adult; Diagnosis, Differential; Exophthalmos; Eye Abnormalities; Eye Pain; Female; Graves Ophthalmop | 2012 |
Severe Graves' ophthalmopathy after percutaneous ethanol injection in a nontoxic thyroid nodule.
Topics: Administration, Cutaneous; Ethanol; Graves Ophthalmopathy; Humans; Hyperthyroidism; Immunoglobulins, | 2012 |
Clinical features of thyroid-associated ophthalmopathy in clinically euthyroid Korean patients.
Topics: Adult; Euthyroid Sick Syndromes; Eyelid Diseases; Female; Graves Ophthalmopathy; Humans; Hyperthyroi | 2012 |
Association of TSH receptor antibody, thyroid stimulating antibody, and thyroid blocking antibody with clinical activity score and degree of severity of Graves ophthalmopathy.
Topics: Adipose Tissue; Adult; Cross-Sectional Studies; Female; Graves Ophthalmopathy; Humans; Immunoglobuli | 2012 |
Increased serum interleukin-17 in Graves' ophthalmopathy.
Topics: Adult; Female; Flow Cytometry; Graves Ophthalmopathy; Humans; Immunoassay; Immunoglobulins, Thyroid- | 2012 |
Endocrine exophthalmos; an evaluation of present knowledge.
Topics: Exophthalmos; Graves Ophthalmopathy; Hormones; Pituitary Gland; Pituitary Gland, Anterior; Thyroxine | 1954 |
Endocrine exophthalmos. Effects of thyrotropin preparations and the thyroxin isomers. Quantitative evaluations in guinea pigs.
Topics: Animals; Exophthalmos; Graves Ophthalmopathy; Guinea Pigs; Pituitary Hormones, Anterior; Thyrotropin | 1961 |
[CONTRIBUTION TO THE EXPERIMENTAL STUDY OF ENDOCRINE EXOPHTHALMOS].
Topics: Adrenocorticotropic Hormone; Animals; Blood; Estradiol; Estrone; Exophthalmos; Fishes; Graves Ophtha | 1963 |
Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; B-Lymphocytes; Femal | 2006 |
CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy.
Topics: Adolescent; Adult; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Female; | 2006 |
Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Calsequestrin; Cell Cycle Proteins; Collagen; Enzyme | 2006 |
Predicting outcome of treatment with radiotherapy in endocrine ophthalmopathy.
Topics: Adult; Aged; Autoantibodies; C-Reactive Protein; Confidence Intervals; Data Interpretation, Statisti | 2007 |
A treatment strategy for Graves' orbitopathy.
Topics: Antithyroid Agents; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Methimazole; Middle Aged | 2007 |
Efficacy and safety of orbital decompression in treatment of thyroid-associated ophthalmopathy: long-term follow-up of 78 patients.
Topics: Adult; Case-Control Studies; Chi-Square Distribution; Decompression, Surgical; Diplopia; Exophthalmo | 2007 |
No changes in serum concentrations of interleukin 10 (IL-10) and interferon gamma (IF-gamma) before and after treatment of the thyroid eye disease (TED).
Topics: Apoptosis; Biomarkers; Cytokines; Glucocorticoids; Graves Ophthalmopathy; Humans; Inflammation; Inte | 2007 |